Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction
Public ClinicalTrials.gov record NCT03888378. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled Study of the Efficacy and Safety of HY02 Ointment in Subjects With Inflamed Meibomian Gland Dysfunction
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the efficacy and safety of two strengths of HY02 Ointment versus Vehicle administered twice daily for twelve weeks in subjects with a diagnosis of Inflamed Meibomian Gland Dysfunction.
Study identification
- NCT ID
- NCT03888378
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 270 participants
Conditions and interventions
Interventions
- 0.3% Topical Minocycline Ointment Drug
- 1% Topical Minocycline Ointment Drug
- Topical Vehicle Ointment Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 1, 2019
- Primary completion
- Sep 17, 2020
- Completion
- Jan 31, 2021
- Last update posted
- Mar 4, 2021
2019 – 2021
United States locations
- U.S. sites
- 20
- U.S. states
- 10
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical site - 4 | Azusa | California | 91702 | — |
| Clinical site - 16 | Huntington Beach | California | 92647 | — |
| Clinical site - 12 | Inglewood | California | 90301 | — |
| Clinical site - 13 | Mission Hills | California | 91345 | — |
| Clinical site 10 | Rancho Cordova | California | 95670 | — |
| Clinical site - 15 | Jacksonville | Florida | 32256 | — |
| Clinical Site - 18 | Largo | Florida | 33773 | — |
| Clinical site - 6 | Indianapolis | Indiana | 46260 | — |
| Clinical site - 20 | New Albany | Indiana | 47150 | — |
| Clinical site - 19 | Kansas City | Missouri | 64111 | — |
| Clinical site - 3 | St Louis | Missouri | 63131 | — |
| Clinical site - 9 | St Louis | Missouri | 63131 | — |
| Clinical site - 7 | Las Vegas | Nevada | 89145 | — |
| Clinical site - 5 | Asheville | North Carolina | 28803 | — |
| Clinical site - 11 | Mason | Ohio | 45040 | — |
| Clinical site - 2 | Memphis | Tennessee | 38119 | — |
| Clinical site - 14 | Cedar Park | Texas | 78613 | — |
| Clinical Site - 1 | El Paso | Texas | 79902 | — |
| Clinical site - 8 | League City | Texas | 77573 | — |
| Clinical site - 17 | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03888378, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2021 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03888378 live on ClinicalTrials.gov.